Federal State Unitary Enterprise «St. Petersburg Scientific Research Institute of Vaccines and Sera and Biopharmaceutical Plant» under Federal Medical Biological Agency takes care of the quality, effectiveness and safety of the medicines released into circulation.
The company has introduced a system for recording messages from medical personal, patients, and distributors, and actively monitors information about the development of adverse reactions or lack of effectiveness
If you know about side effect that could be associated with taking a medicinal product of SPbSRIVS FMBA of Russia, please report us any convenient way.
